CN104805069A - 一种固定化转氨酶及其在合成西他列汀中间体中的应用 - Google Patents
一种固定化转氨酶及其在合成西他列汀中间体中的应用 Download PDFInfo
- Publication number
- CN104805069A CN104805069A CN201510063978.7A CN201510063978A CN104805069A CN 104805069 A CN104805069 A CN 104805069A CN 201510063978 A CN201510063978 A CN 201510063978A CN 104805069 A CN104805069 A CN 104805069A
- Authority
- CN
- China
- Prior art keywords
- transaminase
- enzyme
- immobilization
- mycobacterium
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000340 Transaminases Proteins 0.000 title claims abstract description 49
- 102000003929 Transaminases Human genes 0.000 title claims abstract description 49
- WJPYOCIWVYDFDT-UHFFFAOYSA-N ethyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate Chemical compound CCOC(=O)CC(=O)CC1=CC(F)=C(F)C=C1F WJPYOCIWVYDFDT-UHFFFAOYSA-N 0.000 title description 3
- 230000002194 synthesizing effect Effects 0.000 title 1
- 102000004190 Enzymes Human genes 0.000 claims abstract description 54
- 108090000790 Enzymes Proteins 0.000 claims abstract description 54
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 10
- 239000000661 sodium alginate Substances 0.000 claims abstract description 10
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 10
- 238000006555 catalytic reaction Methods 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 13
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 claims description 12
- 101100246550 Caenorhabditis elegans pyr-1 gene Proteins 0.000 claims description 10
- 241000186359 Mycobacterium Species 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 238000005406 washing Methods 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 6
- 241000142559 Mycobacterium vanbaalenii Species 0.000 claims description 6
- 150000001728 carbonyl compounds Chemical class 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 claims description 6
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 claims description 6
- 229960001327 pyridoxal phosphate Drugs 0.000 claims description 6
- 238000005891 transamination reaction Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 4
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 150000001412 amines Chemical class 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 claims description 4
- 230000003287 optical effect Effects 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 239000001488 sodium phosphate Substances 0.000 claims description 4
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 4
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 3
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 125000004104 aryloxy group Chemical group 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 239000007853 buffer solution Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 claims description 2
- 125000003729 nucleotide group Chemical group 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 abstract description 27
- 238000000034 method Methods 0.000 abstract description 24
- 230000000694 effects Effects 0.000 abstract description 14
- 230000008569 process Effects 0.000 abstract description 11
- 238000000926 separation method Methods 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 238000004064 recycling Methods 0.000 abstract description 2
- 230000003100 immobilizing effect Effects 0.000 abstract 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 17
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 14
- 239000000758 substrate Substances 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 230000009466 transformation Effects 0.000 description 9
- 229910021529 ammonia Inorganic materials 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 108010091086 Recombinases Proteins 0.000 description 3
- 102000018120 Recombinases Human genes 0.000 description 3
- -1 carbonyl diimine Chemical compound 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 238000003259 recombinant expression Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- AQIUVNMAXGKRCG-UHFFFAOYSA-N CC(C(=C=O)CC1=CC(=C(C=C1F)F)F)C(=O)O Chemical compound CC(C(=C=O)CC1=CC(=C(C=C1F)F)F)C(=O)O AQIUVNMAXGKRCG-UHFFFAOYSA-N 0.000 description 2
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- JMANVNJQNLATNU-UHFFFAOYSA-N oxalonitrile Chemical compound N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 229960004115 sitagliptin phosphate Drugs 0.000 description 2
- RTZRUVMEWWPNRR-UHFFFAOYSA-N tert-butyl n-(3-iodo-1h-pyrrolo[2,3-b]pyridin-5-yl)carbamate Chemical compound CC(C)(C)OC(=O)NC1=CN=C2NC=C(I)C2=C1 RTZRUVMEWWPNRR-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- FFEDDUASZCKHMB-SNVBAGLBSA-N (3R)-3-amino-4-(2,4,5-trifluorophenyl)butan-2-one Chemical class N[C@@H](C(C)=O)CC1=C(C=C(C(=C1)F)F)F FFEDDUASZCKHMB-SNVBAGLBSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 241000186063 Arthrobacter Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- TWYJCLFFVWYHFH-UYBGKAFVSA-N C[C@H](C(CC1=CC(=C(C=C1F)F)F)N)C(=O)O Chemical compound C[C@H](C(CC1=CC(=C(C=C1F)F)F)N)C(=O)O TWYJCLFFVWYHFH-UYBGKAFVSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 238000011914 asymmetric synthesis Methods 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229910000071 diazene Inorganic materials 0.000 description 1
- 238000006193 diazotization reaction Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 125000002228 disulfide group Chemical group 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000009144 enzymatic modification Effects 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropyl acetate Chemical class CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 229940090473 januvia Drugs 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000012958 reprocessing Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- MFFMDFFZMYYVKS-SECBINFHSA-N sitagliptin Chemical compound C([C@H](CC(=O)N1CC=2N(C(=NN=2)C(F)(F)F)CC1)N)C1=CC(F)=C(F)C=C1F MFFMDFFZMYYVKS-SECBINFHSA-N 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
Landscapes
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Abstract
Description
编号 | 酶 | 酶活收率(%) | 比酶活(U/g) |
1 | 游离酶 | 100 | 434 |
2 | 固定化酶 | 87.4 | 757 |
批次 | 反应时间(h) | 转化率 | 残余酶活 |
1 | 24 | >99% | 98% |
5 | 24 | >99% | 97% |
10 | 24 | >98% | 96% |
15 | 24 | >98% | 95% |
20 | 24 | >97% | 92% |
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510063978.7A CN104805069B (zh) | 2015-02-06 | 2015-02-06 | 一种固定化转氨酶及其在合成西他列汀中间体中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510063978.7A CN104805069B (zh) | 2015-02-06 | 2015-02-06 | 一种固定化转氨酶及其在合成西他列汀中间体中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104805069A true CN104805069A (zh) | 2015-07-29 |
CN104805069B CN104805069B (zh) | 2017-11-17 |
Family
ID=53690270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510063978.7A Active CN104805069B (zh) | 2015-02-06 | 2015-02-06 | 一种固定化转氨酶及其在合成西他列汀中间体中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104805069B (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105316369A (zh) * | 2015-12-10 | 2016-02-10 | 江苏理工学院 | 一种海藻酸钠固定卤醇脱卤酶催化合成(r)-4-氰基-3-羟基丁酸乙酯的工艺 |
CN106191148A (zh) * | 2016-07-27 | 2016-12-07 | 苏州汉酶生物技术有限公司 | (r)‑3‑氨基‑4‑(2,4,5‑三氟苯基)丁酸叔丁酯的生物制备方法 |
CN106834376A (zh) * | 2017-01-05 | 2017-06-13 | 湖北省宏源药业科技股份有限公司 | 一种酶催化合成西格列汀的方法 |
WO2019007146A1 (zh) * | 2017-07-05 | 2019-01-10 | 浙江工业大学 | 一种氨基转移酶、突变体及其制备西他列汀的应用 |
CN109234327A (zh) * | 2017-07-11 | 2019-01-18 | 上海弈柯莱生物医药科技有限公司 | 一种立体选择性的转氨酶在不对称合成手性胺中的应用 |
CN109251925A (zh) * | 2017-07-14 | 2019-01-22 | 上海蓝木化工有限公司 | 一种离子交换树脂固定化转氨酶的制备及其应用 |
CN110106130A (zh) * | 2019-05-23 | 2019-08-09 | 浙江工业大学 | 一种转氨酶-辅酶共固定化工程菌细胞及应用 |
CN114195664A (zh) * | 2021-12-30 | 2022-03-18 | 辰欣药业股份有限公司 | 一种磷酸西格列汀关键中间体的制备方法 |
US11459549B2 (en) | 2018-05-10 | 2022-10-04 | China Fortune Way Company | Method for biocatalytic synthesis of Sitagliptin and intermediate thereof |
EP4273254A1 (en) | 2022-05-06 | 2023-11-08 | Enzymicals AG | Enzymatic method for preparing (r)-3-amino-4-aryl-butanoic acid derivatives |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103608355A (zh) * | 2011-06-24 | 2014-02-26 | 默沙东公司 | 固定化转氨酶和生产及使用固定化转氨酶的方法 |
-
2015
- 2015-02-06 CN CN201510063978.7A patent/CN104805069B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103608355A (zh) * | 2011-06-24 | 2014-02-26 | 默沙东公司 | 固定化转氨酶和生产及使用固定化转氨酶的方法 |
Non-Patent Citations (3)
Title |
---|
COPELAND ET AL: "CP000511.1", 《GENBANK》 * |
张春红等: "海藻酸钠固定化谷氨酰胺转胺酶稳定性的研究", 《食品工业科技》 * |
张飞等: "缬氨酸转氨酶固定化细胞的制备", 《中国调味品》 * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105316369A (zh) * | 2015-12-10 | 2016-02-10 | 江苏理工学院 | 一种海藻酸钠固定卤醇脱卤酶催化合成(r)-4-氰基-3-羟基丁酸乙酯的工艺 |
CN106191148B (zh) * | 2016-07-27 | 2020-09-25 | 苏州汉酶生物技术有限公司 | (r)-3-氨基-4-(2,4,5-三氟苯基)丁酸叔丁酯的生物制备方法 |
CN106191148A (zh) * | 2016-07-27 | 2016-12-07 | 苏州汉酶生物技术有限公司 | (r)‑3‑氨基‑4‑(2,4,5‑三氟苯基)丁酸叔丁酯的生物制备方法 |
CN106834376A (zh) * | 2017-01-05 | 2017-06-13 | 湖北省宏源药业科技股份有限公司 | 一种酶催化合成西格列汀的方法 |
WO2019007146A1 (zh) * | 2017-07-05 | 2019-01-10 | 浙江工业大学 | 一种氨基转移酶、突变体及其制备西他列汀的应用 |
CN110914417B (zh) * | 2017-07-11 | 2020-10-27 | 弈柯莱生物科技(上海)股份有限公司 | 一种立体选择性的转氨酶在不对称合成手性胺中的应用 |
CN110914417A (zh) * | 2017-07-11 | 2020-03-24 | 上海弈柯莱生物医药科技有限公司 | 一种立体选择性的转氨酶在不对称合成手性胺中的应用 |
CN109234327A (zh) * | 2017-07-11 | 2019-01-18 | 上海弈柯莱生物医药科技有限公司 | 一种立体选择性的转氨酶在不对称合成手性胺中的应用 |
US11499172B2 (en) * | 2017-07-11 | 2022-11-15 | Abiochem Biotechnology Co., Ltd. | Use of stereoselective transaminase in asymmetric synthesis of chiral amine |
CN109251925A (zh) * | 2017-07-14 | 2019-01-22 | 上海蓝木化工有限公司 | 一种离子交换树脂固定化转氨酶的制备及其应用 |
US11459549B2 (en) | 2018-05-10 | 2022-10-04 | China Fortune Way Company | Method for biocatalytic synthesis of Sitagliptin and intermediate thereof |
CN110106130A (zh) * | 2019-05-23 | 2019-08-09 | 浙江工业大学 | 一种转氨酶-辅酶共固定化工程菌细胞及应用 |
CN114195664A (zh) * | 2021-12-30 | 2022-03-18 | 辰欣药业股份有限公司 | 一种磷酸西格列汀关键中间体的制备方法 |
EP4273254A1 (en) | 2022-05-06 | 2023-11-08 | Enzymicals AG | Enzymatic method for preparing (r)-3-amino-4-aryl-butanoic acid derivatives |
WO2023214011A1 (en) | 2022-05-06 | 2023-11-09 | Enzymicals Ag | Enzymatic method for preparing (r)-3-amino-4-aryl-butanoic acid derivatives |
Also Published As
Publication number | Publication date |
---|---|
CN104805069B (zh) | 2017-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104805069A (zh) | 一种固定化转氨酶及其在合成西他列汀中间体中的应用 | |
CN105219745A (zh) | 一种固定化转氨酶及其在合成西他列汀中间体中的应用 | |
CN109134594B (zh) | 一种酶法制备谷胱甘肽的方法 | |
Min et al. | Conjugate-base-stabilized Brønsted acids as asymmetric catalysts: enantioselective Povarov reactions with secondary aromatic amines. | |
CN103333942B (zh) | 左旋吡喹酮的合成方法 | |
Heydari et al. | Trifluoroethanol as a metal-free, homogeneous and recyclable medium for the efficient one-pot synthesis of α-amino nitriles and α-amino phosphonates | |
CN103396440A (zh) | 一种草铵膦的制备方法 | |
CN103555683B (zh) | 一种沙格列汀手性中间体的合成方法 | |
CN106676142A (zh) | 一种手性氨基杂环化合物及其衍生物的制备方法 | |
CN105063120B (zh) | 一种左乙拉西坦的制备方法 | |
CN105624128B (zh) | 一种固定化单胺氧化酶及其在合成手性氮杂双环化合物中的应用 | |
WO2015055127A1 (zh) | 一种左旋吡喹酮的制备方法 | |
CN108675943A (zh) | 一种沙库巴曲关键中间体的制备方法 | |
CN102827912A (zh) | 两酶一步法制备医药中间体d-7-aca的工艺 | |
CN106748854A (zh) | 一种屈昔多巴的制备方法 | |
CA1148884A (en) | Optically pure heterocyclic aminoacid compounds, a process for their production and their use for the synthesis of medicaments | |
CN104402793A (zh) | 一种3-取代氧化吲哚衍生物及其合成方法和应用 | |
CN104610186A (zh) | 提纯氨基苯并噁嗪酮粗品的方法和丙炔氟草胺的制备方法 | |
CN105734089A (zh) | 一种不对称合成(r)-3-氨基哌啶衍生物的方法 | |
CN110129306A (zh) | 固定化转氨酶及其应用 | |
CN102888431A (zh) | 一种制备l-叔亮氨酸的方法 | |
CN107298683B (zh) | 一种手性苯并二氮杂*化合物的合成方法 | |
CN107434811B (zh) | 一种草铵膦纯化的方法 | |
CN106117204B (zh) | 雷迪帕韦中间体(1R,3S,4S)‑2‑Boc‑2‑氮杂双环[2.2.1]戊烷‑3‑羧酸的制备方法 | |
CN109776505B (zh) | 一种阿伐那非的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170630 Address after: 200120 China (Shanghai) free trade zone, Pudong South Road, No. 2, building C110, room Applicant after: ABIOCHEM BIOTECHNOLOGY Co.,Ltd. Address before: Pu Si Road in Pukou District of Nanjing City, Jiangsu province 210032 No. 18 Taishan street, science and Technology Innovation Park 1 building 408 room Applicant before: NANJING ABIOCHEM BIOMEDICAL TECHNOLOGY CO.,LTD. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: Room 3114, Building B, 555 Dongchuan Road, Minhang District, Shanghai, 200241 Patentee after: Ecolab Biotechnology (Shanghai) Co.,Ltd. Address before: 200120 China (Shanghai) free trade zone, Pudong South Road, No. 2, building C110, room Patentee before: ABIOCHEM BIOTECHNOLOGY Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: Room 3114, Building B, 555 Dongchuan Road, Minhang District, Shanghai, 200241 Patentee after: Yikelai Biotechnology (Group) Co.,Ltd. Address before: Room 3114, Building B, 555 Dongchuan Road, Minhang District, Shanghai, 200241 Patentee before: Ecolab Biotechnology (Shanghai) Co.,Ltd. |